Matches in SemOpenAlex for { <https://semopenalex.org/work/W1854477667> ?p ?o ?g. }
- W1854477667 endingPage "920" @default.
- W1854477667 startingPage "911" @default.
- W1854477667 abstract "Liver metastases are associated with a poor prognosis. We investigated the use of hepatic arterial infusion (HAI) of irinotecan combination therapy in patients with liver metastases.Patients with histologically confirmed advanced cancer with liver metastases that was refractory to standard therapy were eligible. A standard 3 + 3 phase I study design was used to determine the dose-limiting toxicity (DLT) and the maximum tolerated dose (MTD). Three cohorts were evaluated: HAI of irinotecan with systemic intravenous (IV) (a) bevacizumab, (b) oxaliplatin and bevacizumab, or (c) bevacizumab and cetuximab.From October 2009 through December 2013, 98 patients with various tumor types were enrolled (median age, 62 years, range, 34-85; and median number of prior therapies, 4, range, 1-11). In cohorts A and C, dose escalation continued until the highest dose level-considered the MTD-was reached. In cohort B, dose escalation continued until dose level 3, and dose level 2 was considered the MTD. Rates of grade 3/4 adverse events were as follows: diarrhea, 8 %; fatigue, 4 %; neutropenia, 4 %; thrombocytopenia, 2 %; and skin rash, 2 %. Seventy-seven patients were evaluable for response. Partial response was noted in 5 (6.5 %) patients (neuroendocrine cancer, n = 2; CRC, n = 2; NSCLC, n = 1); and stable disease ≥ 6 months in 17 (22.1 %) patients (CRC, n = 13; breast, n = 1; neuroendocrine, n = 1; NSCLC, n = 1; pancreatic, n = 1).HAI irinotecan in combination with bevacizumab; oxaliplatin plus bevacizumab; or cetuximab plus bevacizumab was safe and may be a treatment option for selected patients with advanced cancer and liver involvement." @default.
- W1854477667 created "2016-06-24" @default.
- W1854477667 creator A5005436649 @default.
- W1854477667 creator A5009068086 @default.
- W1854477667 creator A5022841891 @default.
- W1854477667 creator A5026095888 @default.
- W1854477667 creator A5036211173 @default.
- W1854477667 creator A5044840107 @default.
- W1854477667 creator A5053481267 @default.
- W1854477667 creator A5060749148 @default.
- W1854477667 creator A5061237827 @default.
- W1854477667 creator A5071768100 @default.
- W1854477667 creator A5071800834 @default.
- W1854477667 creator A5080242644 @default.
- W1854477667 creator A5088433932 @default.
- W1854477667 date "2015-05-21" @default.
- W1854477667 modified "2023-10-18" @default.
- W1854477667 title "Dose-finding study of hepatic arterial infusion of irinotecan-based treatment in patients with advanced cancers metastatic to the liver" @default.
- W1854477667 cites W119872925 @default.
- W1854477667 cites W1480716635 @default.
- W1854477667 cites W1663737385 @default.
- W1854477667 cites W1774923611 @default.
- W1854477667 cites W1777256341 @default.
- W1854477667 cites W1810617563 @default.
- W1854477667 cites W1869323251 @default.
- W1854477667 cites W1935579689 @default.
- W1854477667 cites W1937363859 @default.
- W1854477667 cites W1961040537 @default.
- W1854477667 cites W1968036731 @default.
- W1854477667 cites W1968524205 @default.
- W1854477667 cites W1972877504 @default.
- W1854477667 cites W1975919808 @default.
- W1854477667 cites W1977832090 @default.
- W1854477667 cites W1979423262 @default.
- W1854477667 cites W1979521671 @default.
- W1854477667 cites W1991412742 @default.
- W1854477667 cites W2023489673 @default.
- W1854477667 cites W2031922993 @default.
- W1854477667 cites W2032507182 @default.
- W1854477667 cites W2057062939 @default.
- W1854477667 cites W2059420456 @default.
- W1854477667 cites W2095889631 @default.
- W1854477667 cites W2104155173 @default.
- W1854477667 cites W2106656437 @default.
- W1854477667 cites W2119686162 @default.
- W1854477667 cites W2124515527 @default.
- W1854477667 cites W2126255521 @default.
- W1854477667 cites W2127191258 @default.
- W1854477667 cites W2127752492 @default.
- W1854477667 cites W2128403792 @default.
- W1854477667 cites W2128799395 @default.
- W1854477667 cites W2136866696 @default.
- W1854477667 cites W2138515053 @default.
- W1854477667 cites W2139248078 @default.
- W1854477667 cites W2140752221 @default.
- W1854477667 cites W2146598063 @default.
- W1854477667 cites W2154505306 @default.
- W1854477667 cites W2157769714 @default.
- W1854477667 cites W2161534604 @default.
- W1854477667 cites W2161563098 @default.
- W1854477667 cites W2167341045 @default.
- W1854477667 cites W2167676775 @default.
- W1854477667 cites W2168645047 @default.
- W1854477667 cites W2170653283 @default.
- W1854477667 cites W2261826041 @default.
- W1854477667 cites W2261898534 @default.
- W1854477667 cites W2269945922 @default.
- W1854477667 cites W2411469901 @default.
- W1854477667 cites W2415180153 @default.
- W1854477667 cites W4231068650 @default.
- W1854477667 cites W53031263 @default.
- W1854477667 doi "https://doi.org/10.1007/s10637-015-0251-5" @default.
- W1854477667 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4492845" @default.
- W1854477667 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25990659" @default.
- W1854477667 hasPublicationYear "2015" @default.
- W1854477667 type Work @default.
- W1854477667 sameAs 1854477667 @default.
- W1854477667 citedByCount "7" @default.
- W1854477667 countsByYear W18544776672016 @default.
- W1854477667 countsByYear W18544776672017 @default.
- W1854477667 countsByYear W18544776672018 @default.
- W1854477667 countsByYear W18544776672019 @default.
- W1854477667 crossrefType "journal-article" @default.
- W1854477667 hasAuthorship W1854477667A5005436649 @default.
- W1854477667 hasAuthorship W1854477667A5009068086 @default.
- W1854477667 hasAuthorship W1854477667A5022841891 @default.
- W1854477667 hasAuthorship W1854477667A5026095888 @default.
- W1854477667 hasAuthorship W1854477667A5036211173 @default.
- W1854477667 hasAuthorship W1854477667A5044840107 @default.
- W1854477667 hasAuthorship W1854477667A5053481267 @default.
- W1854477667 hasAuthorship W1854477667A5060749148 @default.
- W1854477667 hasAuthorship W1854477667A5061237827 @default.
- W1854477667 hasAuthorship W1854477667A5071768100 @default.
- W1854477667 hasAuthorship W1854477667A5071800834 @default.
- W1854477667 hasAuthorship W1854477667A5080242644 @default.
- W1854477667 hasAuthorship W1854477667A5088433932 @default.
- W1854477667 hasBestOaLocation W18544776672 @default.
- W1854477667 hasConcept C121608353 @default.